Alan C. Tang, Nicholas A. Besley, Rose Trimpey-Warfhatig, Ping Yang, Howard Wessel, Larry Brown, Ziv Kirshner, Glenn J. Jaffe, The novel secretome ST266 activates Akt and protects against oxidative stress-mediated injury in human RPE and Müller cells, Experimental Eye Research, 2024, 110060, ISSN 0014-4835
Category: Publication
Human amnionic progenitor cell secretome mitigates the consequence of traumatic optic neuropathy in a mouse model
Robyn McCartan, Arissa Gratkowski, Mackenzie Browning, Coral Hahn-Townsend, Scott Ferguson, Alexander Morin, Corbin Bachmeier, Andrew Pearson, Larry Brown, Michael Mullan, Fiona Crawford, Radouil Tzekov, Benoit Mouzon, Human amnionic progenitor cell secretome mitigates the consequence of traumatic optic neuropathy in a mouse model, Molecular Therapy – Methods & Clinical Development, 2023, 29: 303-318, ISSN 2329-0501
The administration of amnion-derived multipotent cell secretome ST266 protects against necrotizing enterocolitis in mice and piglets
Chhinder P. Sodhi, Raheel Ahmad, Hongpeng Jia, William B. Fulton, Carla Lopez, Andres J. Gonzalez Salazar, Asuka Ishiyama, Maame Sampah, Steven Steinway, Sanxia Wang, Thomas Prindle Jr., Menghan Wang, David L. Steed, Howard Wessel, Ziv Z. Kirshner, Larry R. Brown, Peng Lu, and David J. Hackam, The administration of amnion-derived multipotent cell secretome ST266 protects against necrotizing enterocolitis in mice and piglets, American Journal of Physiology-Gastrointestinal and Liver Physiology, 323: G265–G282, 2022, doi:10.1152/ajpgi.00364.2021
Exploratory Phase II Multicenter, Open-Label, Clincal Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects
Jeng, Bennie H., Hamrah, Pedram. Kirshner, Ziv Z., Mendez, Benjamin C., Wessel, Howard C., Brown, Larry R., Steed, David L. (January 2022).
Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects. Translational Vision Science & Technology January 2022 Volume 11 No 1 Article 8.